000 | 01760ngm a2200337 a 4500 | ||
---|---|---|---|
001 | HST8021_1_2 | ||
003 | UkLoHST | ||
006 | m c | ||
007 | cr|cna|||a|||| | ||
007 | vz|czazum | ||
008 | 080121s2004 enk|||||||||||s|||v|eng d | ||
028 | 5 | 0 |
_a8021 _bHenry Stewart Talks |
035 | _a(UkLoHST)39 | ||
035 | _a(UkLU-K)AC000392876 | ||
040 |
_aUkLU-K _beng _cUkLU-K |
||
100 | 1 |
_aGoldstein, D. B. _q(David B.) _4spk |
|
245 | 1 | 0 |
_aHaplotype-based mapping in pharmacogenetics _h[electronic resource] / _cDavid Goldstein. |
246 | 3 | _aHaplotype-based mapping and pharmacogenetics | |
260 |
_aLondon : _bHenry Stewart Talks, _c2004. |
||
300 |
_a1 online resource (1 streaming video file (34 min.) : _bcolor, sound). |
||
490 | 1 |
_aGenetic epidemiology I : fundamentals, theory, practice and latest developments, _x2056-452X |
|
500 | _aAnimated audio-visual presentation with synchronized narration. | ||
500 | _aTitle from title frames. | ||
505 | 0 | _aContents: Pharmacogenetics: a simpler complex trait? -- Mapping strategies: map-based and sequence-based -- Tagging SNPs: definition and assessment -- Case study: tagging in 56 drug transport and metabolism genes -- tSNP efficiency: influence of sample size, SNP frequency and SNP density -- Case study: ABCB1 and anti-epileptic drug resistance -- Associated interval. | |
506 | _aAccess restricted to subscribers. | ||
538 | _aMode of access: World Wide Web. | ||
650 | 2 |
_aGenetic Predisposition to Disease _xepidemiology. |
|
830 | 0 |
_aHenry Stewart talks. _pBiomedical & life sciences collection. _pGenetic epidemiology I : fundamentals, theory, practice and latest developments. |
|
856 | 4 | 0 | _uhttps://hstalks.com/bs/39/ |
856 | 4 | 2 |
_uhttps://hstalks.com/bs/p/25/ _3Series |
999 |
_c78363 _d78363 |